ÂÜÀòÂÒÂ×

Geraldine Ferron-Brady is a highly experienced professional in the field of clinical pharmacology, currently serving as Senior Director of Clinical Pharmacology Modeling and Simulation at GSK since January 2011. In this role, Geraldine provides expertise in clinical pharmacokinetics and pharmacometrics for various oncology projects and contributes to clinical development plans and protocols. Prior to GSK, Geraldine held several positions at sanofi-aventis, including Associate Director and Assistant Director, where contributions included leading Modeling and Simulation expert groups and conducting analyses for innovative drug candidates. Earlier experience at Wyeth Research included roles as Research Leader and Clinical Pharmacokineticist. Geraldine holds a PhD in Pharmaceutics from the University at Buffalo and a PharmD in Pharmacokinetics from Université Paris Cité.